copaydosingefficacyresourcesafety

THIS SITE IS INTENDED FOR US AUDIENCES ONLY

How to administer Otezla® (apremilast)

Otezla is administered orally.1,2

Please read the Prescribing Information for instructions on how to administer Otezla.

Dosing

After an initial 5-day titration period, the maintenance dose of Otezla is 30 mg twice daily.1

5-day titration schedule

Day 1
Day 2
Day 3
Day 4
Day 5
Day 6 and thereafter
5-day titration schedule
AMAMPMAMPMAMPMAMPMAMPM
10
mg
10
mg
10
mg
10
mg
20
mg
20
mg
20
mg
20
mg
30
mg
30
mg
30
mg
 
AM
PM
Day 110 mg-
Day 210 mg10 mg
Day 310 mg20 mg
Day 420 mg20 mg
Day 520 mg30 mg
Day 6 and thereafter30 mg30 mg
  • This titration is intended to reduce the gastrointestinal symptoms associated with initiation of therapy
  • Otezla can be administered without regard to meals
  • Patients should not crush, split, or chew the tablet

The dose of Otezla should be reduced to 30 mg once daily in patients with severe renal impairment1*

  • For initial dosage titration, it is recommended that Otezla be titrated using only the AM schedule shown above and the PM doses be skipped
  • From day 6 on, the dose of Otezla is 30 mg once daily
*

Creatinine clearance (CrCl) <30 mL/min estimated by the Cockcroft–Gault equation.

How to Start

Information on how to start patients on Otezla is included in the prescribing information. Additional guidance for starter packs or for 28-day or 30-day packs of Otezla is included here. If you need to obtain starter packs, please request a rep.

References: 1. Otezla [package insert]. Summit, NJ:Celgene Corporation. 2. Data on file, Celgene Corporation.

Indications & Important Safety Information

Please click here for Full Prescribing Information.

You are leaving the Otezla® (apremilast) website

Do you wish to leave this site?

Are You a
Healthcare Professional?

The FDA approves a new indication for Otezla® (apremilast) Learn more about this treatment option for your patients
EXPLORE